Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Incidence of tuberculosis in HIV-infected patients in Spain: the impact of treatment for LTBI.

Martínez-Pino I, Sambeat MA, Lacalle-Remigio JR, Domingo P; VACH Cohort Study Group.

Int J Tuberc Lung Dis. 2013 Dec;17(12):1545-51. doi: 10.5588/ijtld.13.0070.

PMID:
24200266
2.

Hepatitis-B virus infection predicts mortality of HIV and hepatitis C virus coinfected patients.

Teira R; VACH Study Group.

AIDS. 2013 Mar 13;27(5):845-8. doi: 10.1097/QAD.0b013e32835ecaf7.

PMID:
23380966
3.

Factors associated with liver fibrosis in intravenous drug users coinfected with HIV and HCV.

Cartón JA, Collazos J, de la Fuente B, García-Alcalde ML, Suarez-Zarracina T, Rodríguez-Guardado A, Asensi V.

Antivir Ther. 2011;16(1):27-35. doi: 10.3851/IMP1708.

PMID:
21311106
4.

Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditions.

Rubio R, Serrano O, Carmena J, Asensi V, Echevarría S, Flores J, Ribera E, Zarraga M, Ocampo A, de la Fuente B, Sepúlveda MA, Mariño AI, Minguez C, Vicent R, Cartón JA, Moyano B, Esteban H, Mahillo B, Serrano L, González-García J; GESIDA 44/04 SIMPATAZ Study Group.

HIV Med. 2010 Oct 1;11(9):545-53. doi: 10.1111/j.1468-1293.2010.00827.x. Epub 2010 Mar 19.

5.

Characteristics and outcome of HIV infection in gypsies in the Spanish VACH Cohort.

Teira R, Suárez-Lozano I, Lozano F, Viciana P, Domingo P, Galindo P, Geijo P, Terrón A, González J, Cosín J, Ribera E, Roca B, García-Alcalde ML, Sánchez T, Muñoz-Sánchez A, Vergara A, López-Aldeguer J, Pedrol E, Vidal F, Garrido M, Santamaría JM.

Enferm Infecc Microbiol Clin. 2010 May;28(5):266-72. doi: 10.1016/j.eimc.2009.04.018. Epub 2010 Feb 2.

PMID:
20129716
6.

Association of HIV transmission categories with sociodemographic, viroimmunological and clinical parameters of HIV-infected patients.

Collazos J, Asensi V, Carton JA; Grupo Español para el Estudio Multifactorial de la Adherencia (GEEMA).

Epidemiol Infect. 2010 Jul;138(7):1016-24. doi: 10.1017/S0950268809991282. Epub 2009 Nov 27.

PMID:
19941690
7.

Bacterial meningitis in HIV-1-infected patients in the era of highly active antiretroviral therapy.

Domingo P, Suarez-Lozano I, Torres F, Pomar V, Ribera E, Galindo MJ, Cosin J, Garcia-Alcalde ML, Vidal F, Lopez-Aldeguer J, Roca B, Gonzalez J, Lozano F, Garrido M; VACH Cohort Study Group.

J Acquir Immune Defic Syndr. 2009 Aug 15;51(5):582-7. doi: 10.1097/QAI.0b013e3181adcb01.

PMID:
19512939
8.

Effectiveness and safety of didanosine, lamivudine and efavirenz versus zidovudine, lamivudine and efavirenz for the initial treatment of HIV-infected patients from the Spanish VACH cohort.

Crespo M, Ribera E, Suárez-Lozano I, Domingo P, Pedrol E, López-Aldeguer J, Muñoz A, Viladés C, Sánchez T, Viciana P, Teira R, García-Alcalde ML, Vergara A, Lozano F, Galindo MJ, Cosin J, Roca B, Terrón A, Geijo P, Vidal F, Garrido M; VACH Cohort Study Group.

J Antimicrob Chemother. 2009 Jan;63(1):189-96. doi: 10.1093/jac/dkn450. Epub 2008 Nov 6.

PMID:
18988678
9.

[A 28 year-old woman non-HIV with Kaposi's sarcoma, thrombocytopenic purpura and hypogammaglobulinemia].

Fonseca Aizpuru EM, Arias Miranda I, García-Alcalde ML, Nuño Mateo FJ.

An Med Interna. 2008 Feb;25(2):100. Spanish. No abstract available.

10.

[Longitudinal study on adherence, treatment satisfaction, and effectiveness of once-daily versus twice-daily antiretroviral therapy in a Spanish cohort of HIV-infected patients (CUVA study)].

Viciana P, Rubio R, Ribera E, Knobel H, Iribarren JA, Arribas JR, Pérez-Molina JA; Investigadores del Estudio CUVA.

Enferm Infecc Microbiol Clin. 2008 Mar;26(3):127-34. Spanish.

PMID:
18358210
11.

First-line antiretroviral therapy with efavirenz or lopinavir/ritonavir plus two nucleoside analogues: the SUSKA study, a non-randomized comparison from the VACH cohort.

Domingo P, Suárez-Lozano I, Torres F, Teira R, Lopez-Aldeguer J, Vidal F, Muñoz A, Viciana P, Lozano F, Vergara A, Roca B, García Alcalde ML, Cosín J, Terrón A, Galindo MJ, Geijo P, Ribera E, Gonzalez J, Sanchez T, Lacalle JR, Garrido M.

J Antimicrob Chemother. 2008 Jun;61(6):1348-58. doi: 10.1093/jac/dkn121. Epub 2008 Mar 20.

PMID:
18356150
12.

[Delayed diagnosis of HIV infection in the Spanish VACH cohort [1997-2002]].

Teira Cobo R, Suárez Lozano I, Santamaría Jáuregui JM, Terrón Pernía A, Domingo Pedrol P, González García J, Cosín Ochaita J, Ribera Pascuet E, Sánchez T, Roca Villanueva B, Viciana Fernández P, García Alcalde ML, Geijo Martínez P, Galindo Puerto P, Vergara Campos A, Lozano de León Naranjo F, Muñoz Sánchez A, Tebas P.

Gac Sanit. 2007 Jan-Feb;21(1):66-9. Spanish.

13.

[Nocardiosis].

Arias-Miranda IM, Nuño-Mateo FJ, Viejo de la Guerra G, García-Alcalde ML.

Enferm Infecc Microbiol Clin. 2005 Dec;23(10):637-8. Spanish. No abstract available.

PMID:
16324560
14.

[Changing trends in HIV epidemics: recent diagnoses in the Spanish VACH cohort (2000-2002)].

Teira R, Suárez-Lozano I, Muñoz P, Viciana P, Lozano F, Galindo MJ, Terrón A, Vergara A, Geijo P, Arribas JR, Cosín J, Domingo P, Ribera E, Roca B, García-Alcalde ML, Sánchez T, Muñoz-Sanz A.

Enferm Infecc Microbiol Clin. 2005 Apr;23(4):213-7. Spanish.

PMID:
15826546
15.

[Infection due to herpes zoster and cryptococcus after initiating high-activity antiretroviral treatment].

Fonseca EM, Nuño FJ, García-Alcalde ML, Menéndez MJ.

Enferm Infecc Microbiol Clin. 2003 Apr;21(4):217-8. Spanish. No abstract available.

PMID:
12681139
16.

Epidemiological trends of HIV infection in Spain: preventative plans have to be oriented to new target populations (Spanish VACH Cohort).

Suárez-Lozano I, Fajardo JM, Garrido M, Roca B, García-Alcalde ML, Geijo P, Selma D, Lozano F, Teira R, Viciana P, Pérez-Cortés S, Domingo P, Menchero A, Galindo MJ, Cosín J, Ribera E, Arribas JR, Lacalle JR.

AIDS. 2002 Dec 6;16(18):2496-9. No abstract available.

PMID:
12461432
17.

[Ergotism in a patient treated with ritonavir and ergotamine].

Gallo C, de la Fuente B, García-Alcalde ML, Antuña A.

Med Clin (Barc). 2002 Oct 26;119(14):558-9. Spanish. No abstract available.

PMID:
12421531
18.

[The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].

Cartón JA, Maradona JA, de Oña M, Asensi V, Melón S, García-Alcalde ML, Rodríguez-Junquera M, Moreno-Torrico A, de Zárraga M.

Med Clin (Barc). 1999 Sep 4;113(6):205-9. Spanish.

PMID:
10472608

Supplemental Content

Loading ...
Support Center